American Century Companies Inc. Grows Position in GE HealthCare Technologies Inc. $GEHC

American Century Companies Inc. raised its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 22.6% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,009,077 shares of the company’s stock after acquiring an additional 555,568 shares during the quarter. American Century Companies Inc. owned approximately 0.66% of GE HealthCare Technologies worth $225,982,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Godsey & Gibb Inc. acquired a new position in GE HealthCare Technologies in the 3rd quarter valued at about $26,000. E Fund Management Hong Kong Co. Ltd. boosted its stake in shares of GE HealthCare Technologies by 130.7% during the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after purchasing an additional 196 shares during the last quarter. Allianz SE grew its holdings in shares of GE HealthCare Technologies by 165.2% during the second quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after buying an additional 218 shares in the last quarter. Oakworth Capital Inc. raised its position in shares of GE HealthCare Technologies by 1,876.2% in the third quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock valued at $31,000 after buying an additional 394 shares during the last quarter. Finally, Piscataqua Savings Bank raised its position in shares of GE HealthCare Technologies by 173.4% in the third quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock valued at $36,000 after buying an additional 300 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ:GEHC opened at $84.27 on Friday. The business has a 50-day moving average of $82.38 and a two-hundred day moving average of $78.44. The firm has a market capitalization of $38.41 billion, a PE ratio of 18.48, a P/E/G ratio of 1.85 and a beta of 1.08. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $90.26.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The business had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The company’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be given a $0.035 dividend. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 3.07%.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on GEHC. Piper Sandler raised their target price on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a research report on Friday, January 30th. BTIG Research raised their price objective on GE HealthCare Technologies from $87.00 to $91.00 and gave the stock a “buy” rating in a report on Wednesday, February 4th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $98.00 price objective on shares of GE HealthCare Technologies in a research report on Friday, January 9th. Evercore upped their target price on GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th. Finally, Bank of America raised their price target on GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research note on Monday, January 5th. Seven research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Hold” and a consensus target price of $92.50.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.